Table 3

Systematic review: recurrent neurologic thromboembolic events with transcatheter PFO closure compared to medical treatment

Recurrent eventsPFO closureMedical treatmentRDNNTRR (95% CI)P Value
*Adjusted by indirect standardisation for imbalances in diabetes and smoking.
NNT, number needed to treat; RD, risk difference; RR, relative risk; TIA, transient ischaemic attack.
Crude annualised rate
    Stroke0.42%3.09%2.67%370.144 (0.056 to 0.372)<0.0001
    TIA1.43%2.58%1.15%870.562 (0.299 to 1.058)0.0703
    Stroke or TIA1.86%5.80%3.94%250.327 (0.198 to 0.538)<0.0001
Crude rate of stroke/TIA at 1 year2.71%7.56%4.85%210.357 (0.234 to 0.543)<0.0001
Adjusted annual rate of stroke/TIA*1.86%5.42%3.56%280.346 (0.209 to 0.573)<0.0001
Adjusted rate stroke/TIA at 1 year*2.71%7.07%4.36%230.385 (0.252 to 0.589)<0.0001